That 2013 order was a judicial overreaction that nearly crippled our ability to bring new medicines to Indian patients. It created so much red tape and fear that global trials moved elsewhere. My own team spent two years just getting one cardiac drug back on track, losing crucial research time. Khuda meherban, we need trials, but with sensible rules, not blanket stops.
#exams#study
Jump in to reply — no account needed.